Evogene Ltd chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.03
Dividend & YieldN/A$ (N/A)
Beta 1.12
Market capitalization 26.1M
Operating cash flow -29.5M
ESG Scores unknown

Company description

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -279k -167k -368k 753k
Total Cashflows From Investing Activities 17.35M 37.14M 9.41M -20.57M
Net Borrowings -597k -597k -639k -580k
Total Cash From Financing Activities 297k 9.31M 20.37M 30.28M
Change To Operating Activities 146k -918k -931k 1.05M
Issuance Of Stock 9k 18.72M 18.72M 30.07M
Net Income -20.76M -18.11M -23.37M -27.79M
Change In Cash 2.38M 28.94M 11.48M -13.9M
Effect Of Exchange Rate -114k 159k 1.21M 1.1M
Total Cash From Operating Activities -15.16M -17.67M -19.51M -24.72M
Depreciation 2.02M 2.77M 2.73M 2.23M
Change To Account Receivables -28k 88k -150k -59k
Other Cashflows From Financing Activities 288k 9.9M 2.3M 790k
Change To Netincome 3.74M -1.33M 2.37M -813k
Capital Expenditures -374k -900k -682k -847k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 14.69M 15.79M 17.29M 21.12M
Income Before Tax -20.78M -19.09M -26.17M -30.43M
Net Income -20.76M -18.11M -23.37M -27.79M
Selling General Administrative 5.6M 5.79M 7.99M 9.99M
Gross Profit 295k 419k 466k 163k
Ebit -19.99M -21.17M -24.81M -30.95M
Operating Income -19.99M -21.17M -24.81M -30.95M
Interest Expense -302k -302k -237k -315k
Income Tax Expense 30k 24k 32k 13k
Total Revenue 1.75M 753k 1.04M 930k
Cost Of Revenue 1.45M 334k 574k 767k
Total Other Income ExpenseNet -793k 2.08M -1.36M 521k
Net Income From Continuing Ops -20.81M -19.11M -26.21M -30.45M
Net Income Applicable To Common Shares -20.76M -18.11M -23.37M -27.79M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 8.39M 11.15M 15.03M 12.88M
Total Stockholder Equity 50.05M 50.14M 46.05M 53.65M
Other Current Liabilities 1.4M 423k 5.5M 1.78M
Total Assets 58.69M 71.36M 71.92M 76.3M
Common Stock 142k 142k 200k 234k
Other Current Assets 47k 47k 47k 77k
Retained Earnings -137.79M -155.9M -179.28M -207.07M
Treasury Stock
Cash 5.81M 34.75M 46.23M 32.33M
Total Current Liabilities 5.43M 5.75M 9.68M 6.88M
Other Stockholder Equity
Property, Plant, and Equipment 3.19M 5.25M 3.94M 4.18M
Total Current Assets 55.49M 49.03M 51.82M 56.89M
Net Tangible Assets 50.05M 33.07M 29.91M 38.45M
Net Receivables 675k 1.21M 2.17M 1.17M
Accounts Payable 1.01M 1M 863k 1.46M


Insider Transactions

Here are the insider transactions of stock shares related to Evogene Ltd:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Evogene Ltd. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Evogene Ltd

Here is the result of two systematic investment strategies applied to Evogene Ltd. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Evogene Ltd

The following chart shows the equity curve of the two systematic investment strategies applied to Evogene Ltd:

Evogene Ltd automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 34.54% on the backtest period.

Performance at glance

Performance

34.54 %

Latent gain

604.14 $

Invested capital

1749.12 $

Annualized return

8.42 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Evogene Ltd

This is the result of two momentum investment strategies applied to Evogene Ltd. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Evogene Ltd

The following chart shows all the entries opened by the momentum investment system on Evogene Ltd:

Evogene Ltd momentum entries
  • The first momentum investment strategy would give 37.76% of return on Evogene Ltd. That represents 1604.35$ of latent gain with 4248.77$ of employed capital.
  • The second momentum investment strategy would give 34.38% of return on Evogene Ltd. That represents 1204.79$ of latent gain with 3504.46$ of employed capital.
Performance at glance (1Q Momentum)

Performance

37.76 %

Latent gain

1604.35 $

Invested capital

4248.77 $

Annualized return

-10.26 %
Performance at glance (2Q Momentum)

Performance

34.38 %

Latent gain

1204.79 $

Invested capital

3504.46 $

Annualized return

9.5 %

Momentum equity curve on Evogene Ltd

The following chart shows the equity curve of the two momentum strategies applied to Evogene Ltd:

Evogene Ltd momentum equity

Note: the dividends potentially given by Evogene Ltd are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Evogene Ltd

The following chart shows the employed capital evolution of the two momentum strategies on Evogene Ltd since the beginning:

Evogene Ltd

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Evogene Ltd

Buy the dip entry openings on Evogene Ltd

Evogene Ltd

The performance achieved by the robo-advisor on Evogene Ltd is -21.55%. That represents -54.0$ of latent gain with 250.56$ of employed capital. The following chart shows Evogene Ltd stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Evogene Ltd, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-21.55 %

Latent gain

-54.0 $

Invested capital

250.56 $

Annualized return

-10.26 %

Equity curve of the strategy applied to Evogene Ltd

The following chart shows the result of the investment strategy applied to Evogene Ltd:

Evogene Ltd

Note: the dividends potentially given by Evogene Ltd are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Evogene Ltd

The following chart shows the employed capital evolution since the beginning of the investment strategy on Evogene Ltd:

Evogene Ltd

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Evogene Ltd

In this section, I will compare the three previous investment strategies applied to Evogene Ltd.

Equity curve comparison on Evogene Ltd

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Evogene Ltd investment strategy comparison

Employed capital comparison on Evogene Ltd

Evogene Ltd investment comparison

Performance comparison on Evogene Ltd

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 34.54% 604.14$ 1749.12$ 8.42%
Momentum 1 quarter 37.76% 1604.35$ 4248.77$ 9.78%
Momentum 2 quarters 34.38% 1204.79$ 3504.46$ 9.5%
Non-directional -21.55% -54.0$ 250.56$ -10.26%
Annualized return comparison

Automatic investment

8.42 %

Momentum 1Q

9.5 %

Momentum 2Q

9.5 %

Non-directional

-10.26 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Evogene Ltd:

Positive correlations

Most correlated stocks this year

  • Evogene Ltd

  • Most correlated stocks last 3 months

  • Investors Title Company
  • Waterstone Financial Inc
  • CHINA 33MEDIA
  • Cambridge Bancorp
  • Great Elm Capital Corp
  • Organogenesis Holdings Inc - Class A
  • Signet Jewelers Ltd
  • American National Bankshares Inc
  • Northrim Bancorp Inc
  • HNI Corp
  • Preformed Line Products Company
  • NL Industries Inc
  • Party City Holdco Inc
  • National Cinemedia Inc
  • BlackRock Capital Investment Corp
  • Merchants Bancorp
  • Northwest Bancshares Inc
  • Live Oak Bancshares Inc
  • Peapack-Gladstone Financial Corp
  • H&R Block Inc
  • South Jersey Industries Inc
  • Crown Crafts Inc
  • CNO Financial Group Inc
  • Dave & Buster`s Entertainment Inc
  • Designer Brands Inc - Class A
  • Entravision Communications Corp - Class A
  • Invacare Corp
  • Tenneco Inc - Class A
  • Evogene Ltd
  • Service Properties Trust
  • Ebix Inc
  • Extreme Networks Inc
  • Cadence Bancorporation - Class A
  • Carlisle Companies Inc
  • Albany International Corp - Class A
  • OneMain Holdings Inc
  • Watts Water Technologies Inc - Class A
  • Southern First Bancshares Inc
  • Pathward Financial Inc
  • Synchrony Financial
  • EchoStar Corp - Class A
  • Ryman Hospitality Properties Inc
  • U.S. Silica Holdings Inc
  • Helix Energy Solutions Group Inc
  • Ducommun Inc
  • EDAP TMS S.A.
  • Dillard`s Inc - Class A
  • Select Energy Services Inc - Class A
  • First Northwest Bancorp
  • Cumulus Media Inc - Class A
  • Southern Missouri Bancorp Inc
  • Estee Lauder Cos. Inc - Class A
  • THARISA PLC ORD USD0.001 (DI)
  • Golden Entertainment Inc
  • Avid Technology Inc
  • PlayAGS Inc
  • Golar Lng
  • Global X SuperDividend REIT ETF
  • UBS AG London Branch
  • Sysco Corp
  • iStar Inc
  • Glaukos Corporation
  • Grupo Aeroportuario Del Pacifico SAB de CV
  • PARK LAWN CORPORATION

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between Evogene Ltd and the other stocks. There may be false positives or some missing correlated stocks. If the price of Evogene Ltd does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Evogene Ltd
    Country Israel
    City Rehovot
    Address 13 Gad Feinstein Street
    Phone 972 8 931 1900
    Website www.evogene.com
    FullTime employees 133
    Industry Biotechnology
    Sector Healthcare
    Exchange XNAS
    Ticker EVGN
    Market www.nasdaq.com

    Evogene Ltd ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown